The role of NLRP3 inflammasome activation in the exacerbation of obesity-mediated metabolic disorders and many other diseases opens new avenues for treating or relieving complications associated with these disorders. The gene discussed is NLRP3; the disease is obesity due to melanocortin 4 receptor deficiency.